Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN4341 |
IVHD-valtrate
|
Mdm2; BCL; PARP; Caspase; p53 | Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair; Proteases/Proteasome |
VHD-valtrate has anticancer effects against human ovarian cancer cells in vitro and in vivo, it is a potential therapeutic agent for ovarian cancer, providing a basis for development of the compound as a novel chemotherapeutic agent. |